Amoxicillin for children, a very popular and helpful antibiotic, has been in low supply in the United States since October 28th, which has caused problems for parents and pharmacies.
According to reports, manufacturing, quality issues, delays, and discontinuations contributed to the drug’s inclusion on the FDA’s list of shortages.
The medication treats ear infections, bronchitis, strep throat, and other bacterial illnesses.
The “amoxicillin oral powder” that pharmacists use to produce a liquid version of the simple medication for young children is notably affected by the shortage. The flu, COVID-19, RSV, and other viral diseases are not treated with amoxicillin.
Amoxicillin shortages in various dosages have been reported by Hikma Pharmaceuticals, Teva, and Sandoz.
A lack of baby formula has plagued parents since last spring, making it challenging to give their children the nutrition they need.
Parents are dealing with significant children’s medication scarcity as the cold and flu season has just begun. I’m hoping this can be fixed fast.